BMO Capital Starts ARMO BioSciences, Inc. (ARMO) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St recovers as yields ease; Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
Jefferies Starts ARMO BioSciences, Inc. (ARMO) at Buy
February 20, 2018 2:23 AM ESTJefferies initiates coverage on ARMO BioSciences, Inc. (NASDAQ: ARMO) with a Buy rating and a price target of $61.00.
For an analyst ratings summary and ratings history on ARMO BioSciences, Inc. click here. For more ratings news on ARMO BioSciences, Inc. click here.
Shares of ARMO BioSciences, Inc. closed at $53.65 Friday.
... MoreBaird Starts ARMO BioSciences, Inc. (ARMO) at Outperform
February 20, 2018 1:57 AM ESTBaird initiates coverage on ARMO BioSciences, Inc. (NASDAQ: ARMO) with a Outperform rating and a price target of $67.00.
Analyst Brian Skorney comments "We see ARMO's pegylated, recombinant IL-10, AM0010, as a unique asset in the IO space. It has shown singleagent response... More
